0
Article Tier 2 Sign in to save

Microplastics and Nanoplastics in Human Blood: What the Latest Research Shows

AI summary Read the abstract

This review covers studies from 2022 to 2026 that detected micro- and nanoplastics in human blood. It discusses reported associations with cardiovascular disease and clotting, and whether plasma exchange or blood donation changes particle levels. It stresses contamination risks in measurement and that causation is unproven.

Body Systems
Models

This article reviews recent evidence that microplastics and nanoplastics circulate in human blood. It summarizes landmark detection studies from 2022–2026, including pyrolysis-GC/MS, µFTIR, Raman, and flow-cytometry findings, and discusses associations with cardiovascular disease, plaque vulnerability, coagulation, and cellular injury. It also examines whether therapeutic plasma exchange or blood donation can reduce circulating particle burden, notes methodological limits and contamination risks, and frames remaining questions of causation and mitigation.

More Papers Like This

Article Tier 2

Microplastics and Nanoplastics in Human Blood: What the Latest Research Shows

AI summary Read the abstract

A review of recent evidence that micro- and nanoplastics circulate in human blood, drawing on several detection methods. It covers associations with artery plaque and coagulation and examines plasma exchange and blood donation as research questions. Causation remains an open question.

Article Tier 2

Microplastic particles in human blood and their association with coagulation markers

AI summary Read the abstract

In a study of 36 healthy adults, microplastics were detected in the blood of 89% of participants, with polypropylene and polyethylene being the most common types found. Higher microplastic levels were associated with changes in blood clotting markers, suggesting that plastic particles in our bloodstream may affect how our blood coagulates, though larger studies are needed to confirm this link.

Article Tier 2

Study of Microplastics in Human Blood

AI summary Read the abstract

This study reviewed findings on microplastic contamination in human blood, noting that particles have been detected in the majority of samples tested, while the health consequences remain unclear and warrant urgent further investigation.

Article Tier 2

Effects of micro- and nanoplastics on blood cells in vitro and cardiovascular parameters in vivo, considering their presence in the human bloodstream and potential impact on blood pressure

AI summary Read the abstract

This review examines evidence that micro- and nanoplastics can enter the human bloodstream and interact with blood cells, with plastic particles already detected in human blood, blood clots, and artery plaques. While direct evidence linking microplastics to blood pressure changes in humans is still lacking, animal studies and the mechanisms identified -- including blood vessel damage and inflammation -- suggest cardiovascular effects are plausible.

Article Tier 2

Microplastics and Nanoplastics in Human Blood: Current Evidence, Practical Measurement Limitations, and the Need for Scalable Tests for Public Health Studies and Routine Clinical Use

AI summary Read the abstract

Scientists have found tiny plastic particles (called microplastics and nanoplastics) in human blood using several different testing methods, but this review points out that these methods don't agree with each other well enough to give us a clear, standardized picture of how much plastic is really in our bodies. This matters because without consistent, reliable testing, it's hard to know how exposure to these particles might affect our health over time, the review calls for better, more scalable tests so doctors and researchers can actually track this consistently in the future.

Research digests by email

When a large batch of papers lands in the Atlas, we read through it and send a short write-up of what stood out.

Email me about

Share this paper